Fluorination of amino-quinones enhances anti- Trypanosoma cruzi activity
), revealing a consistent and pronounced enhancement in trypanocidal activity upon fluorine incorporation compared with their non-fluorinated aminoquinone precursors. Notably, several fluorinated aminoquinone exhibited higher trypanocidal activity than benznidazole, the drug currently used in the clinical treatment of Chagas disease. This work highlights the potential of fluorine to beneficially influence the properties and biological activity of quinoidal systems.
Authors
- Rubem F. S. Menna‐Barreto (ORCID: https://orcid.org/0000-0002-1352-0641)
- Zhenhao Zhong (ORCID: https://orcid.org/0000-0002-8019-2166)
- Victor Feliciano dos Santos Ramos (ORCID: https://orcid.org/0009-0005-6208-1621)
- Alastair J. J. Lennox (ORCID: https://orcid.org/0000-0003-2019-7421)
- Renata G. Almeida (ORCID: https://orcid.org/0000-0003-2896-0487)
- Guilherme A. M. Jardim (ORCID: https://orcid.org/0000-0002-9882-3085)
- Eufrânio N. da Silva Júnior (ORCID: https://orcid.org/0000-0003-1281-5453)
- Andrew J. D. Lacey (ORCID: https://orcid.org/0009-0008-7403-1471)
Institutions
- Universidade Federal de Minas Gerais (BR)
- University of Bristol (GB)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6md00631k
- Primary Topic
- Trypanosoma species research and implications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Royal Society
- University of Bristol
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Fundação Oswaldo Cruz
- Worldwide Universities Network
- European Research Council